Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 51

Results For "RIL"

1109 News Found

Health Minister Mandaviya invites Japanese pharma companies to invest in India
Policy | May 16, 2023

Health Minister Mandaviya invites Japanese pharma companies to invest in India

The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030


Mandaviya addresses the G7 Ministerial Meeting on global health architecture
Policy | May 16, 2023

Mandaviya addresses the G7 Ministerial Meeting on global health architecture

Cautions against fragmented & siloed efforts in addressing the challenges faced by the world and underlined the need for collaborative efforts to ensure global health security


Kraiburg TPE is breaking the mold in Asia Pacific’s innovative medical devices
Medical Device | May 15, 2023

Kraiburg TPE is breaking the mold in Asia Pacific’s innovative medical devices

To enhance housing and enclosure design and performance for the Asia Pacific medical devices market, Kraiburg TPE offers the Thermoplast H HC/AP and HC/AD1/AP series


Nippon Express Italia receives IATA CEIV Pharma Certification for Its Facility near Milan Malpensa Airport
Supply Chain | May 13, 2023

Nippon Express Italia receives IATA CEIV Pharma Certification for Its Facility near Milan Malpensa Airport

Milan is also an important hub for the distribution of pharmaceuticals to the rest of Europe


Lilly allocates additional US $50 million to Social Impact Venture Capital portfolio
News | May 12, 2023

Lilly allocates additional US $50 million to Social Impact Venture Capital portfolio

The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries


USFDA approves GSK’s respiratory syncytial virus vaccine ‘Arexvy’
Drug Approval | May 12, 2023

USFDA approves GSK’s respiratory syncytial virus vaccine ‘Arexvy’

Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time


FSD Pharma completes dosing of first cohort in Phase I clinical trial of Lucid-MS
News | May 11, 2023

FSD Pharma completes dosing of first cohort in Phase I clinical trial of Lucid-MS

Lucid-MS is a new drug candidate for the treatment of multiple sclerosis


Baxter  to sell its BioPharma Solutions Business to Advent International and Warburg Pincus for US $4.25billion
News | May 09, 2023

Baxter to sell its BioPharma Solutions Business to Advent International and Warburg Pincus for US $4.25billion

Proposed divestiture of BioPharma Solutions (BPS) further streamlines Baxter’s strategic focus and represents an important milestone in its ongoing business transformation


Wacker acquires Spain-based biotech firm ADL BioPharma
News | May 08, 2023

Wacker acquires Spain-based biotech firm ADL BioPharma

The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters


Astec LifeSciences FY23 PAT declines to Rs. 25.6 Cr
News | May 03, 2023

Astec LifeSciences FY23 PAT declines to Rs. 25.6 Cr

The consolidated EBITDA stood at Rs. 89.3 crore in FY23 as compared to Rs. 164.5 crore in the same period last year